2018-2019 AdooQ 最新目录册 点击此处下载
微信关注
申请试用装

c-Kit

Inhibitory Selectivity
Catalog No.Inhibitor Name c-KitOther
A10290Dasatinib
***
Abl,Src
A10468Imatinib Mesylate
**
PDGFR,v-Abl
A10996Cabozantinib
***
VEGFR2/KDR,c-Met,VEGFR3/FLT4
A10103Axitinib
****
VEGFR1/FLT1,VEGFR2/Flk1,VEGFR2/KDR
A10699Pazopanib HCl
*
VEGFR1,VEGFR2,VEGFR3
A11411Dovitinib
****
FLT3,FGFR1,VEGFR3/FLT4
A10967Vatalanib 2HCl
*
VEGFR2/KDR,VEGFR1/FLT1,VEGFR2/Flk1
A10558Masitinib
*
Lyn B,PDGFRα,PDGFRβ
A10101Tivozanib
**
VEGFR2,VEGFR3,EphB2
A10610Amuvatinib
***
PDGFRα (V561D),FLT3 (D835Y)
A10608Motesanib Diphosphate
***
VEGFR1,VEGFR2,VEGFR2/Flk1
A10679OSI-930
**
FLT1,KDR,CSF-1R
A10502Ki8751
**
VEGFR2,PDGFRα,FGFR2
A10903Telatinib
****
VEGFR3,VEGFR2,PDGFRα
A11518Pazopanib
*
VEGFR1,VEGFR2,VEGFR3
A10198Dovitinib Dilactic Acid
****
FLT3,FGFR1,VEGFR3/FLT4
A16320Dasatinib Monohydrate
***
Abl ,Src
A14156AZD2932
***
PDGFRβ,Flt3,VEGFR-2
A10880Sunitinib Malate
FLT3,PDGFRβ,VEGFR2
A15062DCC-2618
***
PDGFRα, PDGFRβ
A15519PLX647
***
Fms
A15520Pexidartinib (PLX3397)
***
CSF-1R, Flt-3

Notes:
1.Hover mouse over " * " to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of " * " is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.



32 个项目

每页

设置升序顺序
Catalog No. Product Name Application Product Information
A15520 SALE

Pexidartinib (PLX3397)

CSF1/Kit/FLT3 抑制剂
Pexidartinib is a small-molecule receptor tyrosine kinase (RTK) inhibitor of KIT, CSF1R and FLT3 with potential antineoplastic activity.
A10198 SALE

Dovitinib Dilactic acid (TKI258 Dilactic acid)

RTK 抑制剂
Dovitinib is a small-molecule multitargeted receptor tyrosine kinase inhibitor, which inhibits Ba/F3 cells transformed to IL3 independence by ZNF198-FGFR1 or BCR-FGFR1 with IC50 values of 150 nM and 90 nM, respectively.
A10502 SALE

Ki8751

VEGFR-2 抑制剂
Ki8751 is a cell-permeable quinolyloxyphenyl-urea compound that acts as a Flk-1 (VEGFR-2)-selective inhibitior in both cell-based and cell-free assays.
A11518 SALE

Pazopanib (GW-786034)

VEGFR 抑制剂
Pazopanib is a potent and selective multi-targeted receptor tyrosine kinase inhibitor of VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-a/β, and c-kit that blocks tumor growth and inhibits angiogenesis.
A11581 SALE

Toceranib (PHA 291639, SU 11654)

c-Kit, PDGFR, VEGFR 抑制剂
Toceranib is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFRβ.
A11472 SALE

Ki 20227

M-CSFR, CSF1R 抑制剂
Ki 20227 is an inhibitor of c-Fms tyrosine kinase (M-CSFR, CSF1R).
A13530

Flumatinib mesylate

c-Abl/c-Kit/PDGRF?? 抑制剂
Flumatinib mesylate can reduce the expression of C-MYC, HIF-1 a and VEGF in U266 cell line in a time- and dose-dependent manners, so flumatinib mesylate may become a new drug for MM therapy.
A14156

AZD 2932

mutil-targeted protein tyrosine kinase 抑制剂
AZD2932 is a potent and mutil-targeted protein tyrosine kinase inhibitor with IC50 of 8 nM, 4 nM, 7 nM, and 9 nM for VEGFR-2, PDGFRβ, Flt-3, and c-Kit, respectively.
A15062

DCC-2618

C-Kit/PDGFR 抑制剂
DCC-2618 is a small molecule inhibitor of c-Kit and PDGFR with IC50s of 6 nM/30 nM/13 nM for c-Kit/PDGFRα/PDGFRβ respectively.
A15152

Masitinib mesylate

KIT/PDGFR 抑制剂
Masitinib mesylate is a novel inhibitor for Kit and PDGFRα/β with IC50 of 200 nM and 540 nM/800 nM, weak inhibition to ABL and c-Fms.
A15182

N-Desethyl Sunitinib

VEGFR/PDGFR??/KIT 抑制剂
N-desethyl sunitinib is a major and pharmacologically active metabolite of sunitinib, which is potent, ATP-competitive VEGFR, PDGFRβ and KIT inhibitor (Ki values are 2, 9, 17, 8 and 4 nM for VEGFR -1, -2, -3, PDGFRβ and KIT respectively).
A15218

Regorafenib monohydrate

Tyrosine kinase 抑制剂
Regorafenib is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit, RET and Raf-1 with IC50 of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM, respectively.
A15003

AST 487

RET kinase 抑制剂
AST487 is a Ret kinase inhibitor/FLT3 inhibitor with IC50 of 0.88 uM for Ret.
A15519

PLX647

FMS/KIT 抑制剂
PLX647 is a highly specific dual FMS/KIT kinase inhibitor with IC50 of 28/16 nM respectively.
A16258

Flumatinib

multi-kinase 抑制剂
Flumatinib is a multi-kinase inhibitor with IC50 Values of 1.2 nM, 307.6 nM and 2662 nM for c-Abl, PDGFRbeta and c-Kit respectively.
A10880 SALE

Sunitinib Malate

-
Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST).
A10699 SALE

Pazopanib HCl (GW786034)

VEGFR/PDGFR/FGFR 抑制剂
Pazopanib is a potent and selective multi-targeted receptor tyrosine kinase inhibitor of VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-a/β, and c-kit that blocks tumor growth and inhibits angiogenesis.
A10250 SALE

Regorafenib (BAY 73-4506)

VEGFR 抑制剂
Regorafenib (BAY 73-4506) is a multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf. Regorafenib (BAY 73-4506) is an orally bioavailable multikinase inhibitor targeting both the tumor and its vasculature.
A10259 SALE

Imatinib (Gleevec)

PDGFR 抑制剂
Imatinib (Gleevec) is a number of tyrosine kinase enzymes specific inhibitor.
A10103 SALE

Axitinib

VEGFR 抑制剂
Axitinib is a small molecule tyrosine kinase inhibitor,which inhibits multiple targets, including VEGFR-1, VEGFR-2, VEGFR-3, platelet derived growth factor receptor (PDGFR), and cKIT (CD117).
A10996 SALE

XL184 free base (Cabozantinib)

VEGFR 抑制剂
XL184 free base (Cabozantinib) is a small molecule designed to inhibit multiple receptor tyrosine kinases, specifically MET and VEGFR2.
A10558 SALE

Masitinib ( AB1010)

c-Kit 抑制剂
Masitinib (AB1010) is a protein tyrosine kinase inhibitor.
A11411 SALE

Dovitinib (TKI-258)

RTK 抑制剂
Dovitinib is a small-molecule multitargeted receptor tyrosine kinase inhibitor, which inhibits Ba/F3 cells transformed to IL3 independence by ZNF198-FGFR1 or BCR-FGFR1 with IC50 values of 150 nM and 90 nM, respectively.
A10610

MP470 (MP-470, Amuvatinib)

RTK 抑制剂
MP470 is a c-Kit/PDGFR tyrosine kinase inhibitor.
A10101 SALE

Tivozanib (AV-951)

VEGFR 抑制剂
Tivozanib (AV-951) is an oral VEGF receptor tyrosine kinase inhibitor that is designed to inhibit all three VEGF receptors.
A10967 SALE

Vatalanib (PTK787) 2HCl

VEGFR 抑制剂
Vatalanib (PTK787 or PTK/ZK) is a small molecule protein kinase inhibitor that inhibits angiogenesis that inhibits all known VEGF receptors, as well as platelet-derived growth factor receptor-beta and c-kit, but is most selective for VEGFR-2.
A10290 SALE

Dasatinib (BMS-354825)

Abl-Src 抑制剂
Dasatinib (BMS-354825) is an oral multi- BCR/ABL and Src family tyrosine kinase inhibitor. The main targets of dasatinib, are BCR/ABL, Src, c-Kit, ephrin receptors, and several other tyrosine kinases, but not erbB kinases such as EGFR or Her2.
A10468 SALE

Imatinib Mesylate

Bcr-Abl 抑制剂
Imatinib mesylate, a selective tyrosine kinase inhibitor, induced a sustained objective response in treating gastrointestinal stromal tumors with the inhibition of the KIT signal-transduction pathway.
A10903

Telatinib (BAY 57-9352)

VEGFR-2 抑制剂
Telatinib (BAY 57-9352) is an orally available, small-molecule inhibitor of vascular endothelial growth factor receptors 2 and 3 (VEGFR-2/-3) and platelet-derived growth factor receptor β tyrosine kinases.
A10608

Motesanib Diphosphate (AMG-706)

VEGFR 抑制剂
Motesanib, also known as AMG-706, is an orally administered multikinase inhibitor that selectively targets VEGF receptors, platelet-derived growth factor receptors, and Kit receptors.
A10679 SALE

OSI-930

c-Kit/VEGFR 抑制剂
OSI-930 is a potent inhibitor of Kit, KDR, Flt, CSF-1R, c-Raf and Lck with IC50 of 80 nM, 9 nM, 8 nM, 15 nM, 41 nM and 22 nM, respectively.
A16320

Dasatinib Monohydrate

-
Dasatinib Monohydrate is a novel, potent and multi-targeted inhibitor that targets Abl, Src and c-Kit, with IC50 of <1 nM, 0.8 nM and 79 nM, respectively.

32 个项目

每页

设置升序顺序